Literature DB >> 18242356

Diagnosis of urologic malignancies in patients with asymptomatic dipstick hematuria: prospective study with 13 years' follow-up.

Said Fadel Mishriki1, Ghulam Nabi, Nicholas Paul Cohen.   

Abstract

OBJECTIVES: To appraise the outcomes, determine the natural history, and instigate a rationale plan for follow-up of patients with asymptomatic dipstick hematuria.
METHODS: A total of 292 consecutive patients with asymptomatic dipstick hematuria referred between January 1992 and December 1994 were investigated and prospectively followed up. The initial investigations included urinalysis, urine culture and sensitivity, cytology, intravenous urography, with or without ultrasonography, and cystoscopy. Baseline data and follow-up events, particularly the development of urologic malignancy, were recorded for a 13-year period.
RESULTS: Sixteen patients (5.4%) were found to have urologic malignancies on initial evaluation. Of these, 11 died. During a follow-up of 13 years, 21 patients (7%) were lost to follow-up and 42 died of various unrelated causes (other than urologic malignancies). Of the remaining 213 patients, 180 (84.5%) subsequently had negative urinalysis. None with negative urinalysis developed a urologic malignancy during follow-up. The presence of dipstick hematuria persisted in 33 patients. Of these 33 patients, 10 had nephrologic causes, 8 had urinary tract infection, and 15 underwent repeat investigation with no pathologic cause identified. One patient, discharged with negative findings after full initial investigations, presented 2 years later with frank hematuria and was found to have a new bladder tumor.
CONCLUSIONS: Patients presenting with asymptomatic dipstick hematuria who have undergone thorough initial negative investigations can be discharged from tertiary urologic care services. Nephrologic referral is recommended if dipstick hematuria and proteinuria persist. The repetition of the urologic investigations is unwarranted, unless patients present with symptoms or develop frank hematuria.

Entities:  

Mesh:

Year:  2008        PMID: 18242356     DOI: 10.1016/j.urology.2007.08.031

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

Review 1.  Beyond haematuria in uro oncology: imaging biomarkers lag behind needs.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01       Impact factor: 9.236

2.  Japanese guidelines of the management of hematuria 2013.

Authors:  Shigeo Horie; Shuichi Ito; Hirokazu Okada; Haruhito Kikuchi; Ichiei Narita; Tsutomu Nishiyama; Tomonori Hasegawa; Hiroshi Mikami; Kunihiro Yamagata; Tomoji Yuno; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2014-10       Impact factor: 2.801

Review 3.  Emerging Roles of Urine-Based Tumor DNA Analysis in Bladder Cancer Management.

Authors:  Aadel A Chaudhuri; Bruna Pellini; Nadja Pejovic; Pradeep S Chauhan; Peter K Harris; Jeffrey J Szymanski; Zachary L Smith; Vivek K Arora
Journal:  JCO Precis Oncol       Date:  2020-07-15

Review 4.  Evaluation of asymptomatic, atraumatic hematuria in children and adults.

Authors:  William H Tu; Linda D Shortliffe
Journal:  Nat Rev Urol       Date:  2010-03-09       Impact factor: 14.432

5.  High-grade microscopic hematuria in adult men can predict urothelial malignancy.

Authors:  Ahmed Fouad Kotb; Doaa Attia
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

6.  Meta-analysis of efficacy and safety of continuous saline bladder irrigation compared with intravesical chemotherapy after transurethral resection of bladder tumors.

Authors:  Zhongbao Zhou; Shikai Zhao; Youyi Lu; Jitao Wu; Yongwei Li; Zhenli Gao; Diandong Yang; Yuanshan Cui
Journal:  World J Urol       Date:  2019-01-05       Impact factor: 4.226

Review 7.  The Investigation of Hematuria.

Authors:  Christian Bolenz; Bernd Schröppel; Andreas Eisenhardt; Bernd J Schmitz-Dräger; Marc-Oliver Grimm
Journal:  Dtsch Arztebl Int       Date:  2018-11-30       Impact factor: 5.594

8.  Is Dipstick Urinalysis Screening Beneficial in Men with Lower Urinary Tract Symptoms?

Authors:  Franklin C Lowe; Martin C Michel; Jan M Wruck; Anna E Verbeek
Journal:  Adv Ther       Date:  2019-08-07       Impact factor: 3.845

9.  Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Authors:  Simeon U Springer; Chung-Hsin Chen; Maria Del Carmen Rodriguez Pena; Lu Li; Christopher Douville; Yuxuan Wang; Joshua David Cohen; Diana Taheri; Natalie Silliman; Joy Schaefer; Janine Ptak; Lisa Dobbyn; Maria Papoli; Isaac Kinde; Bahman Afsari; Aline C Tregnago; Stephania M Bezerra; Christopher VandenBussche; Kazutoshi Fujita; Dilek Ertoy; Isabela W Cunha; Lijia Yu; Trinity J Bivalacqua; Arthur P Grollman; Luis A Diaz; Rachel Karchin; Ludmila Danilova; Chao-Yuan Huang; Chia-Tung Shun; Robert J Turesky; Byeong Hwa Yun; Thomas A Rosenquist; Yeong-Shiau Pu; Ralph H Hruban; Cristian Tomasetti; Nickolas Papadopoulos; Ken W Kinzler; Bert Vogelstein; Kathleen G Dickman; George J Netto
Journal:  Elife       Date:  2018-03-20       Impact factor: 8.140

10.  Evaluation of Hospital-Based Hematuria Diagnosis and Subsequent Cancer Risk Among Adults in Denmark.

Authors:  Mette Nørgaard; Katalin Veres; Anne Gulbech Ording; Jens Christian Djurhuus; Jørgen Bjerggaard Jensen; Henrik Toft Sørensen
Journal:  JAMA Netw Open       Date:  2018-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.